Migraine Acute Treatment Agents Prior Authorization
Customize your policy alerts
Sign up for all Geisinger Health Plan policy alerts
Know when Geisinger Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
This form governs prior authorization requirements and quantity/daily dose limit requests for acute migraine treatments (triptans, gepants, ditans, ergot alkaloids, NSAIDs, and combination products) for Geisinger Health Plan members. It affects prescribers submitting new or renewal requests and those seeking exceptions to DHS-established quantity/dose limits.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.